Mindin regulates vascular smooth muscle cell phenotype and prevents neointima formation

Clinical Science

Volumn 129, Issue 2, 2015, Pages 129-145

  Zhu, Li Hua ^a,b   Huang, Ling ^a,b   Zhang, Xiaojing ^c   Zhang, Peng ^a,b   Zhang, Shu Min ^a,b   Guan, Hongjing ^a,b   Zhang, Yan ^b   Zhu, Xue Yong ^b   Tian, Song ^b   Deng, Keqiong ^a,b   Li, Hongliang ^a,b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c University of Macau   (Macao)

Author keywords

Mindin; Neointima formation; Vascular injury; Vascular smooth muscle cell

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; MAMMALIAN TARGET OF RAPAMYCIN; MEMBRANE PROTEIN; MINDIN PROTEIN; PLATELET DERIVED GROWTH FACTOR BB; TRANSCRIPTION FACTOR FKHRL1; UNCLASSIFIED DRUG; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; MINDIN; PROTEIN KINASE B; PROTEIN KINASE INHIBITOR; SCLEROPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GAIN OF FUNCTION MUTATION; HUMAN; HUMAN CELL; HYPERPLASIA; NEOINTIMA; NONHUMAN; PHENOTYPE; PHENOTYPIC SWITCHING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASCULAR LESION; VASCULAR SMOOTH MUSCLE CELL; VASCULAR TISSUE; ANIMAL; C57BL MOUSE; CAROTID ARTERY INJURY; CELL CULTURE; CELL DIFFERENTIATION; CELL MOTION; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; KNOCKOUT MOUSE; MALE; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SPRAGUE DAWLEY RAT; TIME; TRANSGENIC RAT; VASCULAR SMOOTH MUSCLE;

ANIMALS; CAROTID ARTERY INJURIES; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION; GENOTYPE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; PHENOTYPE; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84935419405     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20140679     Document Type: Article

References (52)

1. Higashijima, S., Nose, A., Eguchi, G., Hotta, Y. and Okamoto, H. (1997) Mindin/F-spondin family: novel ECM proteins expressed in the zebrafish embryonic axis. Dev. Biol. 192, 211-227.
2. He, Y.W., Li, H., Zhang, J., Hsu, C.L., Lin, E., Zhang, N., Guo, J., Forbush, K.A. and Bevan, M.J. (2004) The extracellular matrix protein mindin is a pattern-recognition molecule for microbial pathogens. Nat. Immunol. 5, 88-97.
3. Jia, W., Li, H. and He, Y.W. (2005) The extracellular matrix protein mindin serves as an integrin ligand and is critical for inflammatory cell recruitment. Blood 106, 3854-3859.
4. Jia, W., Li, H. and He, Y.W. (2008) Pattern recognition molecule mindin promotes intranasal clearance of influenza viruses. J. Immunol. 180, 6255-6261.
5. Li, Y., Cao, C., Jia, W., Yu, L., Mo, M., Wang, Q., Huang, Y., Lim, J.M., Ishihara, M., Wells, L. et al. (2009) Structure of the F-spondin domain of mindin, an integrin ligand and pattern recognition molecule. EMBO J. 28, 286-297.
6. Parry, R., Schneider, D., Hudson, D., Parkes, D., Xuan, J.A., Newton, A., Toy, P., Lin, R., Harkins, R., Alicke, B. et al. (2005) Identification of a novel prostate tumor target, mindin/RG-1, for antibody-based radiotherapy of prostate cancer. Cancer Res. 65, 8397-8405.
7. Frush, S., Li, Z., Potts, E.N., Du, W., Eu, J.P., Garantziotis, S., He, Y.W., Foster, W.M. and Hollingsworth, J.W. (2011) The role of the extracellular matrix protein mindin in airway response to environmental airways injury. Environ. Health Perspect. 119, 1403-1408.
8. Murakoshi, M., Tanimoto, M., Gohda, T., Hagiwara, S., Takagi, M., Horikoshi, S. and Tomino, Y. (2011) Mindin: a novel marker for podocyte injury in diabetic nephropathy. Nephrol. Dial. Transplant. 26, 2153-2160.
9. Zhu, L.H., Wang, A., Luo, P., Wang, X., Jiang, D.S., Deng, W., Zhang, X., Wang, T., Liu, Y., Gao, L. et al. (2014) Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor alpha in mice. J. Hepatol. 60, 1046-1054.
10. Bian, Z.Y., Wei, X., Deng, S., Tang, Q.Z., Feng, J., Zhang, Y., Liu, C., Jiang, D.S., Yan, L., Zhang, L.F. et al. (2012) Disruption of mindin exacerbates cardiac hypertrophy and fibrosis. J. Mol. Med. 90, 895-910.
11. Wang, L., Lu, Y., Zhang, X., Zhang, Y., Jiang, D., Dong, X., Deng, S., Yang, L., Guan, Y., Zhu, L. et al. (2013) Mindin is a critical mediator of ischemic brain injury in an experimental stroke model. Exp. Neurol. 247, 506-516.
12. Yan, L., Wei, X., Tang, Q.Z., Feng, J., Zhang, Y., Liu, C., Bian, Z.Y., Zhang, L.F., Chen, M., Bai, X. et al. (2011) Cardiac-specific mindin overexpression attenuates cardiac hypertrophy via blocking AKT/GSK3beta and TGF-beta1-Smad signalling. Cardiovasc. Res. 92, 85-94.
13. Heusch, G., Libby, P., Gersh, B., Yellon, D., Bohm, M., Lopaschuk, G. and Opie, L. (2014) Cardiovascular remodelling in coronary artery disease and heart failure. Lancet 383, 1933-1943.
14. Gomez, D. and Owens, G.K. (2012) Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc. Res. 95, 156-164.
15. Hering, L., Herse, F., Verlohren, S., Park, J.K., Wellner, M., Qadri, F., Pijnenborg, R., Staff, A.C., Huppertz, B., Muller, D.N. et al. (2008) Trophoblasts reduce the vascular smooth muscle cell proatherogenic response. Hypertension 51, 554-559.
16. Indolfi, C., Mongiardo, A., Curcio, A. and Torella, D. (2003) Molecular mechanisms of in-stent restenosis and approach to therapy with eluting stents. Trends Cardiovasc. Med. 13, 142-148.
17. Chen, Y.E. (2011) Vascular cell lineage determination and differentiation. Arterioscler. Thromb. Vasc. Biol. 31, 1467-1468.
18. Wanjare, M., Kuo, F. and Gerecht, S. (2013) Derivation and maturation of synthetic and contractile vascular smooth muscle cells from human pluripotent stem cells. Cardiovasc. Res. 97, 321-330.
19. Sun, S.G., Zheng, B., Han, M., Fang, X.M., Li, H.X., Miao, S.B., Su, M., Han, Y., Shi, H.J. and Wen, J.K. (2011) miR-146a and Kruppel-like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation. EMBO Rep. 12, 56-62.
20. Greenberg, J.I., Shields, D.J., Barillas, S.G., Acevedo, L.M., Murphy, E., Huang, J., Scheppke, L., Stockmann, C., Johnson, R.S., Angle, N. and Cheresh, D.A. (2008) A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature 456, 809-813.
21. Arita, Y., Kihara, S., Ouchi, N., Maeda, K., Kuriyama, H., Okamoto, Y., Kumada, M., Hotta, K., Nishida, M., Takahashi, M. et al. (2002) Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 105, 2893-2898.
22. Zhang, S.M., Zhu, L.H., Li, Z.Z., Wang, P.X., Chen, H.Z., Guan, H.J., Jiang, D.S., Chen, K., Zhang, X.F., Tian, S. et al. (2014) Interferon regulatory factor 3 protects against adverse neo-intima formation. Cardiovasc. Res. 102, 469-479.
23. Zhang, S.M., Gao, L., Zhang, X.F., Zhang, R., Zhu, L.H., Wang, P.X., Tian, S., Yang, D., Chen, K., Huang, L. et al. (2014) Interferon regulatory factor 8 modulates phenotypic switching of smooth muscle cells by regulating the activity of myocardin. Mol. Cell. Biol. 34, 400-414.
24. Johnson, J.L., Dwivedi, A., Somerville, M., George, S.J. and Newby, A.C. (2011) Matrix metalloproteinase (MMP)-3 activates MMP-9 mediated vascular smooth muscle cell migration and neointima formation in mice. Arterioscler. Thromb. Vasc. Biol. 31, e35-e44.
25. Wang, Y.L., Liu, L.Z., He, Z.H., Ding, K.H. and Xue, F. (2012) Phenotypic transformation and migration of adventitial cells following angioplasty. Exp. Ther. Med. 4, 26-32.
26. Gadang, V., Konaniah, E., Hui, D.Y. and Jaeschke, A. (2014) Mixed-Lineage kinase 3 deficiency promotes neointima formation through increased activation of the RhoA pathway in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 34, 1429-1436.
27. Begum, N., Hockman, S. and Manganiello, V.C. (2011) Phosphodiesterase 3A (PDE3A) deletion suppresses proliferation of cultured murine vascular smooth muscle cells (VSMCs) via inhibition of mitogen-activated protein kinase (MAPK) signaling and alterations in critical cell cycle regulatory proteins. J. Biol. Chem. 286, 26238-26249.
28. Toth, A., Jeffers, J.R., Nickson, P., Min, J.Y., Morgan, J.P., Zambetti, G.P. and Erhardt, P. (2006) Targeted deletion of Puma attenuates cardiomyocyte death and improves cardiac function during ischemia-reperfusion. Am. J. Physiol. Heart Circ. Physiol. 291, H52-H60.
29. Bhattachariya, A., Dahan, D., Turczynska, K.M., Sward, K., Hellstrand, P. and Albinsson, S. (2014) Expression of microRNAs is essential for arterial myogenic tone and pressure-induced activation of the PI3-kinase/Akt pathway. Cardiovasc. Res. 101, 288-296.
30. Yoshida, T. and Owens, G.K. (2005) Molecular determinants of vascular smooth muscle cell diversity. Circ. Res. 96, 280-291.
31. Zhang, S.M., Zhu, L.H., Chen, H.Z., Zhang, R., Zhang, P., Jiang, D.S., Gao, L., Tian, S., Wang, L., Zhang, Y. et al. (2014) Interferon regulatory factor 9 is critical for neointima formation following vascular injury. Nat. Commun. 5, 5160.
32. Roychaudhuri, R., Hergrueter, A.H., Polverino, F., Laucho-Contreras, M.E., Gupta, K., Borregaard, N. and Owen, C.A. (2014) ADAM9 is a novel product of polymorphonuclear neutrophils: regulation of expression and contributions to extracellular matrix protein degradation during acute lung injury. J. Immunol. 193, 2469-2482.
33. Kostourou, V. and Papalazarou, V. (2014) Non-collagenous ECM proteins in blood vessel morphogenesis and cancer. Biochim. Biophys. Acta 1840, 2403-2413.
34. Xu, J. and Shi, G.P. (2014) Vascular wall extracellular matrix proteins and vascular diseases. Biochim. Biophys. Acta 1842, 2106-2119.
35. Malara, A., Currao, M., Gruppi, C., Celesti, G., Viarengo, G., Buracchi, C., Laghi, L., Kaplan, D.L. and Balduini, A. (2014) Megakaryocytes contribute to the bone marrow-matrix environment by expressing fibronectin, type IV collagen, and laminin. Stem Cells 32, 926-937.
36. Larson, A.R., Lee, C.W., Lezcano, C., Zhan, Q., Huang, J., Fischer, A.H. and Murphy, G.F. (2014) Melanoma spheroid formation involves laminin-associated vasculogenic mimicry. Am. J. Pathol. 184, 71-78.
37. Welser, J.V., Lange, N., Singer, C.A., Elorza, M., Scowen, P., Keef, K.D., Gerthoffer, W.T. and Burkin, D.J. (2007) Loss of the alpha7 integrin promotes extracellular signal-regulated kinase activation and altered vascular remodeling. Circ. Res. 101, 672-681.
38. Moura, R., Tjwa, M., Vandervoort, P., Cludts, K. and Hoylaerts, M.F. (2007) Thrombospondin-1 activates medial smooth muscle cells and triggers neointima formation upon mouse carotid artery ligation. Arterioscler. Thromb. Vasc. Biol. 27, 2163-2169.
39. Feinstein, Y. and Klar, A. (2004) The neuronal class 2 TSR proteins F-spondin and mindin: a small family with divergent biological activities. Int. J. Biochem. Cell. Biol. 36, 975-980.
40. Ichii, T., Koyama, H., Tanaka, S., Shioi, A., Okuno, Y., Otani, S. and Nishizawa, Y. (2002) Thrombospondin-1 mediates smooth muscle cell proliferation induced by interaction with human platelets. Arterioscler. Thromb. Vasc. Biol. 22, 1286-1292.
41. Miyamoto, K., Morishita, Y., Yamazaki, M., Minamino, N., Kangawa, K., Matsuo, H., Mizutani, T., Yamada, K. and Minegishi, T. (2001) Isolation and characterization of vascular smooth muscle cell growth promoting factor from bovine ovarian follicular fluid and its cDNA cloning from bovine and human ovary. Arch. Biochem. Biophys. 390, 93-100.
42. Duran-Prado, M., Morell, M., Delgado-Maroto, V., Castano, J.P., Aneiros-Fernandez, J., de Lecea, L., Culler, M.D., Hernandez-Cortes, P., O'Valle, F. and Delgado, M. (2013) Cortistatin inhibits migration and proliferation of human vascular smooth muscle cells and decreases neointimal formation on carotid artery ligation. Circ. Res. 112, 1444-1455.
43. Son, J.E., Lee, E., Jung, S.K., Kim, J.E., Oak, M.H., Lee, K.W. and Lee, H.J. (2014) Anthocyanidins, novel FAK inhibitors, attenuate PDGF-BB-induced aortic smooth muscle cell migration and neointima formation. Cardiovasc. Res. 101, 503-512.
44. Zhu, L., Hao, Y., Guan, H., Cui, C., Tian, S., Yang, D., Wang, X., Zhang, S., Wang, L. and Jiang, H. (2013) Effect of sinomenine on vascular smooth muscle cell dedifferentiation and neointima formation after vascular injury in mice. Mol. Cell. Biochem. 373, 53-62.
45. Jia, S., Chen, Z., Li, J., Chi, Y., Wang, J., Li, S., Luo, Y., Geng, B., Wang, C., Cui, Q. et al. (2014) FAM3A promotes vascular smooth muscle cell proliferation and migration and exacerbates neointima formation in rat artery after balloon injury. J. Mol. Cell. Cardiol. 74, 173-182.
46. Allard, D., Figg, N., Bennett, M.R. and Littlewood, T.D. (2008) Akt regulates the survival of vascular smooth muscle cells via inhibition of FoxO3a and GSK3. J. Biol. Chem. 283, 19739-19747.
47. Aitman, T.J., Boone, C., Churchill, G.A., Hengartner, M.O., Mackay, T.F. and Stemple, D.L. (2011) The future of model organisms in human disease research. Nat. Rev. Genet. 12, 575-582.
48. Aitman, T.J., Critser, J.K., Cuppen, E., Dominiczak, A., Fernandez-Suarez, X.M., Flint, J., Gauguier, D., Geurts, A.M., Gould, M., Harris, P.C. et al. (2008) Progress and prospects in rat genetics: a community view. Nat. Genet. 40, 516-522.
49. Morita, H., Kurihara, H., Yoshida, S., Saito, Y., Shindo, T., Oh-Hashi, Y., Kurihara, Y., Yazaki, Y. and Nagai, R. (2001) Diet-induced hyperhomocysteinemia exacerbates neointima formation in rat carotid arteries after balloon injury. Circulation 103, 133-139.
50. Meng, Q.H., Yang, G., Yang, W., Jiang, B., Wu, L. and Wang, R. (2007) Protective effect of hydrogen sulfide on balloon injury-induced neointima hyperplasia in rat carotid arteries. Am. J. Pathol. 170, 1406-1414.
51. Li, G., Chen, S.J., Oparil, S., Chen, Y.F. and Thompson, J.A. (2000) Direct in vivo evidence demonstrating neointimal migration of adventitial fibroblasts after balloon injury of rat carotid arteries. Circulation 101, 1362-1365.
52. Joung, J.K. and Sander, J.D. (2013) TALENs: a widely applicable technology for targeted genome editing. Nat. Rev. Mol. Cell Biol. 14, 49-55.